| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/03/2004 | US6686185 Modulating metabolism; cardiovascular disorders |
| 02/03/2004 | US6686179 Polypeptide for use in the treatment of thrombosis, cancer, inflammation, autoimmune, and bone disorders |
| 02/03/2004 | US6686178 Fusion proteins; interleukins; colony stimulating factors; cellular proliferation/differentiation; culturing bone marrow or peripheral blood cells; natural killer cells |
| 02/03/2004 | US6686177 Delayed onset of action |
| 02/03/2004 | US6686175 IP-10/MIG receptor designated CXCR3, nucleic acids, and methods of use therefor |
| 02/03/2004 | US6686164 Testing for immunoglobulin e response; for use in foods, detergents, personal care materials |
| 02/03/2004 | US6686163 Coding sequence haplotype of the human BRCA1 gene |
| 02/03/2004 | US6686159 Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression |
| 02/03/2004 | US6686153 PRV-1 gene and the use thereof |
| 02/03/2004 | US6685967 Spray dried powder |
| 02/03/2004 | US6685947 Derived from canine distemper virus |
| 02/03/2004 | US6685943 Fibronectin binding protein compositions and methods of use |
| 02/03/2004 | US6685942 Passive immmunotherapy; fab fragment that neutralizes both antigenic subgroup a and subgroup b |
| 02/03/2004 | US6685941 Immuosuppressant |
| 02/03/2004 | US6685939 Method of preventing the onset of allergic disorders |
| 02/03/2004 | US6685938 Methods and compositions useful for modulation of angiogenesis and vascular permeability using SRC or Yes tyrosine kinases |
| 02/03/2004 | US6685937 Administering an effective amount of at least one lytic enzyme produced by a bacteria infected with a bacteriophage specific for said bacteria to the site of the infection |
| 02/03/2004 | US6685934 Neurodegenerative diseases. |
| 02/03/2004 | US6685933 Interferon α hybrids |
| 02/03/2004 | US6685932 Coiled-coil dimer derived antagonists of 4-helix bundle cytokines, design and uses thereof |
| 02/03/2004 | US6685931 Treatment of hepatitis C virus infections with interleukin-10 |
| 02/03/2004 | US6685930 When binding molecules reach maximum concentration in tumor a liposome conjugated with antibodies is administered to clear them from the blood; single chain vh-vl binding molecules conjugated with peptide linker, solid tissue antigen binder |
| 02/03/2004 | US6685917 Treatment of mucositis |
| 02/03/2004 | US6685911 Sensitization process for antigen-presenting cells and means for implementing the process |
| 02/03/2004 | US6685626 Compositions, devices, methods, and kits for induction of adhesions |
| 02/03/2004 | CA2234151C Urogenital carcinoma tlp complex peptides and antibodies thereof |
| 02/03/2004 | CA2182244C Camptothecin derivatives |
| 02/03/2004 | CA2133086C Skin care method and composition |
| 02/03/2004 | CA2100655C Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 02/03/2004 | CA2091636C Method for suppressing coloring of human serum albumin |
| 02/03/2004 | CA2025597C Vaccine against lyme disease |
| 01/31/2004 | CA2396350A1 Methods of identifying selective .beta.-1-adrenergic receptor antagonists |
| 01/29/2004 | WO2004010146A1 Screening method and anti-tumor drug candidate obtained therefrom |
| 01/29/2004 | WO2004009836A2 Pr/set-domain containing nucleic acids, polypeptides, antibodies and methods of use |
| 01/29/2004 | WO2004009818A1 Nucleic acid sequence coding for enzyme delta-12-desaturase and originating from fragilariopsis cylindrus, associated polypeptide, and use of this nucleic acid sequence and polypeptide |
| 01/29/2004 | WO2004009815A2 Silencing hybrid gene expression |
| 01/29/2004 | WO2004009812A1 Novel protein participating in nuclear migaration of substance in nerve cells, gene encoding the protein and utilization of the same |
| 01/29/2004 | WO2004009799A2 Ion channel receptor and uses thereof |
| 01/29/2004 | WO2004009797A2 Protein modification and maintenance molecules |
| 01/29/2004 | WO2004009778A2 Kinases and phosphatases |
| 01/29/2004 | WO2004009774A2 Protein conjugates with a water-soluble biocompatible, biogradable polymer |
| 01/29/2004 | WO2004009773A2 Methods and compositions for activating or inhibiting vegf-d and vegf-c |
| 01/29/2004 | WO2004009769A2 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOGENESIS |
| 01/29/2004 | WO2004009759A2 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 01/29/2004 | WO2004009637A1 Anti-angiogenic peptides |
| 01/29/2004 | WO2004009636A2 Gnrh modulator |
| 01/29/2004 | WO2004009634A2 Novel polypeptides and nucleic acids encoding same |
| 01/29/2004 | WO2004009630A1 Regulation of human serotonin receptor |
| 01/29/2004 | WO2004009628A1 Inhibition of cell division based use of analogs of neuropeptide y |
| 01/29/2004 | WO2004009620A1 Novel na+/h+ exchanger inhibitor peptide (pinhe) and applications thereof |
| 01/29/2004 | WO2004009619A2 Protein complexes of the tip60 transcriptional activator protein |
| 01/29/2004 | WO2004009616A2 Ghrelin analogs |
| 01/29/2004 | WO2004009615A2 Cd40-ligand lacking native-pattern glycosylation |
| 01/29/2004 | WO2004009614A2 Receptor (sstr4)- selective somatostatin analogs |
| 01/29/2004 | WO2004009131A1 Tumor treating combinations, compositions and methods |
| 01/29/2004 | WO2004009126A1 Targeted agents for nerve regeneration |
| 01/29/2004 | WO2004009124A2 Ghrelin-carrier conjugates |
| 01/29/2004 | WO2004009122A1 Mucoadhesive composition and formulation for solubilization of insoluble drugs and preparation method thereof |
| 01/29/2004 | WO2004009120A1 Hybrid of itraconazole, cyclosporine or carvedilol with a layered silicate and a process for preparing the same |
| 01/29/2004 | WO2004009113A1 Use of convertase inhibitors in the treatment of fibrosis and scarring |
| 01/29/2004 | WO2004009112A1 Use of urease for inhibiting cancer cell growth |
| 01/29/2004 | WO2004009111A1 Corneal epithelium injury-healing accelerator |
| 01/29/2004 | WO2004009110A1 Peptide m as apoptosis inducing agent |
| 01/29/2004 | WO2004009107A1 Body fat percentage-lowering agent or body fat percentage increase inhibitor |
| 01/29/2004 | WO2004009102A1 Use of densin-like compounds |
| 01/29/2004 | WO2004009098A1 Antisense compounds, methods and compositions for treating mmp-12 related inflammatory disorders |
| 01/29/2004 | WO2004009094A1 Methods and compositions for treating diabetes mellitis |
| 01/29/2004 | WO2004009072A2 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| 01/29/2004 | WO2004009066A1 Novel nitric oxide-releasing amidine diazeniumdiolates, compositions and uses thereof and method of making same |
| 01/29/2004 | WO2004009028A2 Method and composition for treating and preventing influenza infection and symptoms thereof |
| 01/29/2004 | WO2004009027A2 Method and composition for treating and preventing herpesvirus infection |
| 01/29/2004 | WO2004009024A2 Modulation of protein kinase c-iota expression |
| 01/29/2004 | WO2004009021A2 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 01/29/2004 | WO2004009018A2 Antisense modulation of ptprm expression |
| 01/29/2004 | WO2004009015A2 Combination therapy for the treatment of obesity |
| 01/29/2004 | WO2004008946A2 Methods of diagnosing and treating pre-eclampsia or clamp |
| 01/29/2004 | WO2003088748A8 Use of heme oxygenase-1 and products of heme degradation |
| 01/29/2004 | WO2003080654B1 Helicobacter flagellar, motility polypeptides |
| 01/29/2004 | WO2003074554A3 Apoptogenic-bacteriocins combining broad spectrum antibiotic and selective anti-tumoral activities, and compositions and uses thereof |
| 01/29/2004 | WO2003072018A3 Ricin vaccine and methods of making and using thereof |
| 01/29/2004 | WO2003070887A3 RNA INTERFERENCE MEDIATED INHIBITION OF POLYCOMB GROUP PROTEIN EZH2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/29/2004 | WO2003070878A3 Antisense modulation of hematopoietic cell protein tyrosine kinase expression |
| 01/29/2004 | WO2003066663A3 Peptides for recognition and targeting of glial cell tumors |
| 01/29/2004 | WO2003065980A3 Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin |
| 01/29/2004 | WO2003059932A3 Methods of inducing or enhancing connective tissue repair |
| 01/29/2004 | WO2003059373A3 Compositions and their use for enhancing and inhibiting fertilization |
| 01/29/2004 | WO2003054157A3 Dna encoding novel cyclic gmp dependent protein kinases from two protozoal sources for use as chemotherapeutic targets for antiprotozoal agents |
| 01/29/2004 | WO2003053337A3 Therapeutic compositions |
| 01/29/2004 | WO2003050241A3 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation |
| 01/29/2004 | WO2003048775A3 Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases |
| 01/29/2004 | WO2003044173A3 Antitumor activity of bok |
| 01/29/2004 | WO2003038113A3 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943 |
| 01/29/2004 | WO2003037912A3 Tri-, tetra-, and penta-peptides having antiangiogenic activity |
| 01/29/2004 | WO2003028654A3 Storage-stable human fibrinogen solutions |
| 01/29/2004 | WO2003020324A3 Methods for sterilizing preparations of digestive enzymes |
| 01/29/2004 | WO2003020111A3 Alternatively spliced circulating tissue factor |
| 01/29/2004 | WO2003018047A3 Hdl for the treatment of stroke and other ischemic conditions |
| 01/29/2004 | WO2003017947A3 Spontaneous emulsions containing cyclosporine |
| 01/29/2004 | WO2003017944A3 Gpi-anchored cytokines |
| 01/29/2004 | WO2003008545A3 Antisense modulation of glioma-associated oncogene-2 expression |